Comparative Effectiveness of Spironolactone Versus Doxycycline for Acne

Comparative Effectiveness of Spironolactone Versus Doxycycline for Acne

Brief description of study

Are you interested in contributing to skin research? Join our Acne Research Study, where we aim to compare the effectiveness of Spironolactone and Doxycycline Hyclate in the treatment of moderate to severe acne in women. Both medications are common treatments for acne, but it is not known how well they compare to one another.

Detailed description of study

Study Overview
Our study seeks to gather valuable insights into the safety, tolerability, and effectiveness of these common acne treatments. It is a comprehensive examination designed to advance our understanding of how these medications compare in the real-world.

Study Components
Participants will undergo dermatological assessments and have the option to participate in a parallel study exploring the impact of these acne treatments on the skin microbiome and antibiotic resistance. Microbiome samples will be collected from specific areas on your face, behind your ear, and your throat.

Study Duration
Your involvement will last up to 16 weeks (4 months), during which you will attend three in-person study visits at the Perelman Center for Advanced Medicine. Compensation of up to $300 is provided for the completion of these study visits and study medication is provided free-of-cost.

Nationwide Collaboration
This study is being conducted at clinics across the United States, allowing us to collect diverse and valuable data.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    acne
  • Age: Between 16 Years - 40 Years
  • Gender: Female

  • Assigned Female at birth
  • Have at least 10 pimples on your face
  • Not pregnant or trying to become pregnant

Updated on 09 Mar 2024. Study ID: 844133

Find a site

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center